FDA's 2026 QMSR update aligns U.S. oversight with ISO 13485:2016 — every Class I, II, and III manufacturer is revisiting their QMS this year. RxQMSR embeds AI agents into the refresh so the compliance work you're doing now builds compounding operational returns for years.
| Process | Current Time | Error / Risk | FTE Cost/Month | Status |
|---|---|---|---|---|
| DHR Assembly | 4–6 hrs/batch | 12% rework rate | $8,400 | Critical |
| CAPA Cycle | 47 days avg | 28% repeat CAPAs | $6,200 | Critical |
| Supplier Scoring | Manual, quarterly | 3 escapes/yr | $3,100 | High Risk |
| Document Control | 5–8 days/revision | 8% version errors | $4,500 | High Risk |
| Change Control | 22 days avg | 15% incomplete | $5,800 | High Risk |
| Metric | Before | After | Improvement | Monthly Value |
|---|---|---|---|---|
| Monthly QA labor | $28,000 | ~$10,000 | 64% reduction | $18,000 saved |
| CAPA cycle | 47 days | 18 days | 62% faster | Inspection-ready |
| DHR rework | 12% | < 2% | 83% reduction | Releases on time |
| Audit readiness | Reactive | Always-on | Continuous | 483 risk down |
| Supplier escapes | 3/yr | ~0 | Eliminated | Product quality |
Half a day of your team's time. Five business days later, you receive your Prescription Report — agent roadmap, ROI model, compliance risk map.